+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

D Alpha Parahydroxy Phenylglycine Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6078580
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The D Alpha Parahydroxy Phenylglycine Market is projected to reach USD 76.16 Million in 2026. It is expected to continue growing at a CAGR of 5.97%, reaching USD 102.58 Million by 2032.

D-Alpha Parahydroxy Phenylglycine: Executive Overview

D-alpha parahydroxy phenylglycine is a chiral intermediate used primarily in pharmaceutical synthesis, particularly in the production of beta-lactam-related active pharmaceutical ingredients. Its strategic importance is linked to stereochemical purity, dependable supply, regulatory compliance, and integration into qualified manufacturing processes. Demand conditions are shaped by antibiotic production, pharmaceutical outsourcing, precursor availability, and the ability of producers to meet rigorous quality specifications.

Supply-Chain Resilience Is Reshaping the Intermediate Landscape

The landscape is shifting from cost-led procurement toward resilience, traceability, and dual sourcing. Pharmaceutical manufacturers increasingly evaluate suppliers through the combined lens of batch consistency, impurity control, documentation, environmental performance, and continuity planning. Producers that can maintain validated processes, secure critical raw materials, and provide transparent change-control documentation are better positioned to support regulated customers. Environmental controls and responsible handling of chemical inputs are also becoming more important as procurement teams extend compliance expectations across the value chain.

Artificial Intelligence Improves Quality, Planning, and Process Control

Artificial intelligence can strengthen this market by identifying process deviations, correlating analytical results with operating conditions, and improving preventive maintenance. Machine-learning tools may also support demand sensing, inventory planning, supplier-risk monitoring, and document review within quality systems. The most credible applications remain human-supervised: laboratory data, validated manufacturing records, and regulatory documentation require controlled governance, explainability, cybersecurity, and adherence to good manufacturing practice. AI can therefore improve responsiveness and consistency, but it does not replace process validation or expert release decisions.

Regional Insights: Regulation and Manufacturing Depth Drive Differentiation

North America combines stringent pharmaceutical quality expectations with strong demand for reliable, documented intermediates. Latin America offers opportunities tied to local pharmaceutical production but requires careful attention to import procedures, currency conditions, and uneven regulatory infrastructure. Europe emphasizes traceability, sustainability, worker safety, and compliance across a mature pharmaceutical ecosystem. The Middle East is developing healthcare and manufacturing capabilities, with supply continuity and localization gaining importance. Africa presents a varied environment in which access, import dependence, and pharmaceutical-industry development differ substantially by country. Asia-Pacific remains central to chemical and pharmaceutical manufacturing, while customers increasingly distinguish suppliers by quality systems, resilience, and regulatory readiness rather than price alone.

Group Insights: Trade, Regulation, and Industrial Policy Shape Demand

ASEAN reflects diverse pharmaceutical capabilities and growing interest in regional supply-chain integration. BRICS economies combine large healthcare systems with significant chemical and pharmaceutical manufacturing capacity, although regulatory approaches and trade conditions vary. The European Union places strong emphasis on harmonized quality, environmental obligations, and supply-chain transparency. G7 markets generally prioritize advanced quality systems, dependable sourcing, and stringent regulatory documentation. GCC countries are supporting healthcare diversification and may favor suppliers capable of meeting localization and continuity requirements. NATO members span different production profiles, but strategic resilience, secure sourcing, and critical-input visibility are increasingly relevant across their pharmaceutical supply chains.

Country Insights: Market Access Depends on Capability and Compliance

Australia relies substantially on international pharmaceutical supply chains and values documented quality and dependable logistics. Brazil combines a substantial domestic healthcare system with complex regulatory and import requirements. Canada emphasizes regulated pharmaceutical quality and secure access to essential inputs. China has extensive chemical and pharmaceutical manufacturing depth, alongside evolving quality, environmental, and export expectations. France, Germany, Italy, and Spain benefit from established European pharmaceutical capabilities and rigorous compliance requirements. India is a major pharmaceutical manufacturing center where process economics, quality consistency, and export documentation are decisive. Japan and South Korea prioritize high technical standards, reliability, and advanced manufacturing discipline. Mexico connects North American and Latin American supply chains, making customs execution and supplier qualification important. Russia’s operating environment is affected by trade restrictions and supply-chain constraints. The United Kingdom maintains strong pharmaceutical expertise and demanding quality expectations. The United States places particular emphasis on supplier qualification, traceability, regulatory documentation, and continuity of supply.

Actions for Leaders: Build Qualified, Resilient, and Data-Enabled Supply

Industry leaders should qualify more than one credible source where feasible, while avoiding uncontrolled proliferation of suppliers that can weaken oversight. They should establish clear specifications for stereochemical purity, related substances, residual solvents, and microbiological quality where applicable, supported by validated analytical methods and robust change-control procedures. Contractual agreements should address notification obligations, audit rights, business continuity, and data integrity. Regional supply-chain mapping can identify dependencies in raw materials, transport, utilities, and regulatory release. Finally, leaders should deploy AI selectively for deviation detection, forecasting, and supplier monitoring, with validation, access controls, and human accountability embedded from the outset.

Research Methodology: Evidence-Led Assessment of the Value Chain

This executive summary uses a structured assessment of the D-alpha parahydroxy phenylglycine value chain. The approach considers the compound’s role as a pharmaceutical intermediate, relevant manufacturing and quality requirements, regulatory and trade conditions, supply-chain resilience, regional industrial characteristics, and the potential application of artificial intelligence. Regional, group, and country perspectives are integrated qualitatively using established considerations such as pharmaceutical manufacturing presence, regulatory maturity, import dependence, logistics, and industrial policy. No unsupported quantitative market claims are used, and conclusions should be validated against current regulatory notices, supplier documentation, customs requirements, and primary industry interviews before commercial decisions are made.

Conclusion: Quality Assurance and Resilience Define Competitive Readiness

D-alpha parahydroxy phenylglycine sits within a pharmaceutical-intermediate ecosystem where dependable quality is inseparable from commercial value. The strongest strategic position comes from combining stereochemical and impurity control with transparent documentation, resilient sourcing, regulatory awareness, and disciplined process improvement. Geographic conditions differ across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, as do the priorities of ASEAN, BRICS, the European Union, G7, GCC, and NATO-linked supply chains. Across the covered countries, organizations that treat the intermediate as a controlled, strategically managed input-not merely a commodity-will be better equipped to protect continuity and meet evolving pharmaceutical standards.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. D Alpha Parahydroxy Phenylglycine Market, by Purity
7.1. Introduction
7.2. High Purity
7.3. Industrial Purity
7.4. Standard Purity
8. D Alpha Parahydroxy Phenylglycine Market, by Manufacturing Process
8.1. Introduction
8.2. Chemical Synthesis
8.3. Enzymatic Synthesis
8.4. Fermentation
9. D Alpha Parahydroxy Phenylglycine Market, by Grade
9.1. Introduction
9.2. Analytical Grade
9.3. Pharmaceutical Grade
9.4. Technical Grade
10. D Alpha Parahydroxy Phenylglycine Market, by Form
10.1. Introduction
10.2. Powder
10.3. Solution
11. D Alpha Parahydroxy Phenylglycine Market, by Application
11.1. Introduction
11.2. Agrochemical Intermediate
11.3. Antibiotic Synthesis
11.3.1. Amoxicillin Production
11.3.2. Ampicillin Production
11.4. Cosmetic Additive
11.5. Pharmaceutical Intermediate
12. D Alpha Parahydroxy Phenylglycine Market, by Sales Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
13. D Alpha Parahydroxy Phenylglycine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. D Alpha Parahydroxy Phenylglycine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. D Alpha Parahydroxy Phenylglycine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. A.H.A International Co., Ltd.
17.2. Ajinomoto Co., Inc.
17.3. Amino GmbH
17.4. Anhui BBCA Pharmaceutical Co., Ltd.
17.5. BASF SE
17.6. Daicel Corporation
17.7. Deretil, S.A.
17.8. Evonik Industries AG
17.9. Hebei Jiheng Group Co., Ltd.
17.10. Hubei Jusheng Technology Co., Ltd.
17.11. Hubei Xingfa Chemicals Group Co., Ltd.
17.12. Jiangsu Feiyue Pharmaceutical Co., Ltd.
17.13. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
17.14. Lonza Group AG
17.15. Mitsubishi Chemical Group Corporation
17.16. National Analytical Corporation
17.17. Ningbo Zhenlei Chemical Co., Ltd.
17.18. Shandong Lukang Pharmaceutical Co., Ltd.
17.19. Shandong Xinhua Pharmaceutical Co., Ltd.
17.20. Shanghai Kangxin Chemical Co., Ltd.
17.21. Sichuan Guoguang Agrochemical Co., Ltd.
17.22. Sichuan Tongsheng Amino Acid Co., Ltd.
17.23. Sumitomo Chemical Co., Ltd.
17.24. Taizhou Yuandong Biotechnology Co., Ltd.
17.25. Wuxi Jinghai Amino Acid Co., Ltd.
17.26. Xiamen Equation Chemical Co.,Ltd
17.27. Zhejiang Huahai Pharmaceutical Co., Ltd.
17.28. Zhejiang NHU Co., Ltd.
17.29. Zhejiang Tianxin Pharmaceutical Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global D Alpha Parahydroxy Phenylglycine Market, Years Considered for the Study
FIGURE 2. Global D Alpha Parahydroxy Phenylglycine Market, Research Design
FIGURE 3. Global D Alpha Parahydroxy Phenylglycine Market, Research Framework
FIGURE 4. Global D Alpha Parahydroxy Phenylglycine Market, Data Triangulation
FIGURE 5. Global D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2025 vs 2032 (%)
FIGURE 7. Global D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2025 vs 2032 (%)
FIGURE 9. Global D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2025 vs 2032 (%)
FIGURE 11. Global D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2025 vs 2032 (%)
FIGURE 13. Global D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global D Alpha Parahydroxy Phenylglycine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global D Alpha Parahydroxy Phenylglycine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global D Alpha Parahydroxy Phenylglycine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global D Alpha Parahydroxy Phenylglycine Market Segmentation & Coverage
TABLE 2. Global D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 3. Global D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 4. Global High Purity Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global High Purity Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global High Purity Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Industrial Purity Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Industrial Purity Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Industrial Purity Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Standard Purity Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Standard Purity Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Standard Purity Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 14. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Enzymatic Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Enzymatic Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Enzymatic Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 24. Global Analytical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Analytical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Analytical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Pharmaceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Pharmaceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Pharmaceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Technical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Technical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Technical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 34. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 41. Global Agrochemical Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Agrochemical Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Agrochemical Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Antibiotic Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Antibiotic Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Antibiotic Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Amoxicillin Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Amoxicillin Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Amoxicillin Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Ampicillin Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Ampicillin Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Ampicillin Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Cosmetic Additive Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Cosmetic Additive Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Cosmetic Additive Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Pharmaceutical Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Pharmaceutical Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Pharmaceutical Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 60. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 75. North America D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. North America D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 77. North America D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 78. North America D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 79. North America D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 80. North America D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. North America D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 82. North America D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 83. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 85. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 86. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 87. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 88. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 90. Latin America D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 91. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 93. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 94. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 95. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 96. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 98. Europe D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 99. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 101. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 102. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 103. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 104. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 106. Middle East D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 107. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 109. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 110. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 111. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 112. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 114. Africa D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. Global D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 118. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 119. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 120. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 121. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 123. ASEAN D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 124. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 126. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 127. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 128. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 129. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 131. GCC D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 132. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 134. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 135. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 136. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 137. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 139. European Union D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 140. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 142. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 143. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 144. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 145. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 147. BRICS D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 148. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 150. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 151. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 152. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 153. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 155. G7 D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 156. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 158. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 159. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 160. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 161. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 163. NATO D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 164. Global D Alpha Parahydroxy Phenylglycine Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. United States D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 166. United States D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 167. United States D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 168. United States D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 169. United States D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 170. United States D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. United States D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 172. United States D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 173. Canada D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 174. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 175. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 176. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 177. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 178. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 180. Canada D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 181. Mexico D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 182. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 183. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 184. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 185. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 186. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 188. Mexico D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 189. Brazil D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 190. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 191. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 192. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 193. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 194. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 196. Brazil D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 197. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 198. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 199. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 200. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 201. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 202. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 204. United Kingdom D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 205. Germany D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 206. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 207. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 208. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 209. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 210. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 212. Germany D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 213. France D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 214. France D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 215. France D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 216. France D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 217. France D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 218. France D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. France D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 220. France D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 221. Russia D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 222. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 223. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 224. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 225. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 226. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 228. Russia D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 229. Italy D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 230. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 231. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 232. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 233. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 234. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 236. Italy D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 237. Spain D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 238. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 239. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 240. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 241. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 242. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 244. Spain D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 245. China D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 246. China D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 247. China D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 248. China D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 249. China D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 250. China D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. China D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 252. China D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 253. India D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 254. India D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 255. India D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 256. India D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 257. India D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 258. India D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. India D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 260. India D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 261. Japan D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 262. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 263. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 264. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 265. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 266. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 268. Japan D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 269. Australia D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 270. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 271. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 272. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 273. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 274. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 276. Australia D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 277. South Korea D Alpha Parahydroxy Phenylglycine Market Size, 2017-2032 (USD Million)
TABLE 278. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Purity, 2017-2032 (USD Million)
TABLE 279. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 280. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Grade, 2017-2032 (USD Million)
TABLE 281. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Form, 2017-2032 (USD Million)
TABLE 282. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Antibiotic Synthesis, 2017-2032 (USD Million)
TABLE 284. South Korea D Alpha Parahydroxy Phenylglycine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 285. Global D Alpha Parahydroxy Phenylglycine Market Share, by Key Player, 2025
TABLE 286. Global D Alpha Parahydroxy Phenylglycine Market, Key Experts

Companies Mentioned

  • A.H.A International Co., Ltd.
  • Ajinomoto Co., Inc.
  • Amino GmbH
  • Anhui BBCA Pharmaceutical Co., Ltd.
  • BASF SE
  • Daicel Corporation
  • Deretil, S.A.
  • Evonik Industries AG
  • Hebei Jiheng Group Co., Ltd.
  • Hubei Jusheng Technology Co., Ltd.
  • Hubei Xingfa Chemicals Group Co., Ltd.
  • Jiangsu Feiyue Pharmaceutical Co., Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Lonza Group AG
  • Mitsubishi Chemical Group Corporation
  • National Analytical Corporation
  • Ningbo Zhenlei Chemical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Shanghai Kangxin Chemical Co., Ltd.
  • Sichuan Guoguang Agrochemical Co., Ltd.
  • Sichuan Tongsheng Amino Acid Co., Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Taizhou Yuandong Biotechnology Co., Ltd.
  • Wuxi Jinghai Amino Acid Co., Ltd.
  • Xiamen Equation Chemical Co.,Ltd
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
  • Zhejiang NHU Co., Ltd.
  • Zhejiang Tianxin Pharmaceutical Co., Ltd.